PTC Therapeutics, Inc.
NasdaqGS:PTCT
$ 25.21
$-0.20 (-0.79%)
$ 25.21
$-0.20 (-0.79%)
End-of-day quote: 04/24/2024

PTCT - PTC Therapeutics Stock Prediction 2025 - 2030

11 years of reliable PTC Therapeutics stock forecast. The Wall Street analysts predict Hold for PTCT. See at a glance whether NasdaqGS:PTCT will rise in the future.

$0.00
Forecast 2023
$30.17
Forecast 2025
$63.39
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$30.17
Forecast 2030
$63.39
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.67
Price-to-book Ratio
N/A
Market Cap
1.94B
TEV
3.48 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$29.15

PTC Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

PTC Therapeutics Stock Forecast 2023

$28.50

In the last five quarters, PTC Therapeutics’s Price Target has fallen from $56.27 to $29.15 - a -48.2% decrease. Thridteen analysts predict that PTC Therapeutics’s share price will fall in the coming year, reaching $28.50. This would represent a decrease of -2.23%.

13.05%
13.05
Last update: 04/25/2024

Highest Price Target $45.00

Average Price Target $28.50

Lowest Price Target $15.00

PTC Therapeutics Stock Prediction 2025

PTC Therapeutics Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $27.39. An increase of 8.64% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $27.64. An increase of 9.64% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $27.89. An increase of 10.65% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $28.15. An increase of 11.65% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $28.40. An increase of 12.65% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $28.65. An increase of 13.66% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $28.91. An increase of 14.66% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $29.16. An increase of 15.66% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $29.41. An increase of 16.67% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $29.66. An increase of 17.67% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $29.92. An increase of 18.67% compared to the previous month's estimate.

PTC Therapeutics Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $30.17. An increase of 19.68% compared to the previous month's estimate.

PTC Therapeutics Stock Forecast 2030

Stock Forecast for the Price of an PTC Therapeutics Share in Jan 2030.

In January 2030, analysts believe the stock price will be $57.55. An increase of 128.27% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Feb 2030.

In February 2030, analysts believe the stock price will be $58.08. An increase of 130.37% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Mar 2030.

In March 2030, analysts believe the stock price will be $58.61. An increase of 132.48% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Apr 2030.

In April 2030, analysts believe the stock price will be $59.14. An increase of 134.59% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in May 2030.

In May 2030, analysts believe the stock price will be $59.67. An increase of 136.7% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Jun 2030.

In June 2030, analysts believe the stock price will be $60.20. An increase of 138.81% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Jul 2030.

In July 2030, analysts believe the stock price will be $60.74. An increase of 140.92% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Aug 2030.

In August 2030, analysts believe the stock price will be $61.27. An increase of 143.03% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Sep 2030.

In September 2030, analysts believe the stock price will be $61.80. An increase of 145.14% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Oct 2030.

In October 2030, analysts believe the stock price will be $62.33. An increase of 147.25% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Nov 2030.

In November 2030, analysts believe the stock price will be $62.86. An increase of 149.35% compared to the previous month's estimate.

Stock Forecast for the Price of an PTC Therapeutics Share in Dec 2030.

In December 2030, analysts believe the stock price will be $63.39. An increase of 151.46% compared to the previous month's estimate.

P/E
0.00
Beta
0.67
Price-to-book Ratio
N/A
Market Cap
1.94B
TEV
3.48 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$29.15

PTC Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching PTC Therapeutics, Inc.?

The following analysts have recently covered PTC Therapeutics:

Barclays
BofA Global Research
Cantor Fitzgerald & Co.
J.P. Morgan
Marktfeld
Raymond James & Associates
RBC Capital Markets
William Blair & Company L.L.C.
Citigroup Inc
Citigroup Inc. Research
Goldman Sachs
Jefferies LLC
Leerink Partners LLC
Morgan Stanley
TD Cowen
Wells Fargo Securities, LLC
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching PTC Therapeutics, Inc.?

The following sell-side analysts have recently covered PTC Therapeutics:

Wang, Huidong
Ahmad, Tazeen
Brill Bongero, Danielle Catherine
Thome, Joseph John-Charles
Joseph, Eric William
Paraskevopoulos, Michail
Davis, Luke
Kluska, Kristen Brianne
Lebowitz, David Neil
Choi, Paul
Shi, Dingding
Schwartz, Joseph Patrick
Hung, Jeff
Fauth, Tiago Felipe
Corwin, Samantha Danielle
(This information refers to the last 90 days.)